32 active trials 32 recruiting 29 disease areas
| Phase 1 | 4 | |
| Phase 1/2 | 28 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 1/2 | ||||
| NCT07744256 | Adaptive Phase 1/2 Study of Dual-Target CAR-NK Cells in Relapsed/Refractory Small Cell… | Small Cell Lung Cancer (SCLC) | Recruiting | 2026-08-04 |
| NCT07641023 | Dual-Target CAR-NK Cells Targeting MSLN, EGFR, or HER2 in Advanced NSCLC | Non-Small Cell Lung Cancer | Recruiting | 2026-06-11 |
| NCT07641036 | Dual-Target HER2/CEA CAR-NK Cells in Advanced Biliary Tract Cancer | Cholangiocarcinoma | Recruiting | 2026-06-11 |
| NCT07627698 | Dual-Target CSPG4/GD2 CAR-NK Cells for Advanced Melanoma | Unresectable Melanoma | Recruiting | 2026-06-04 |
| NCT07627711 | Dual-Target CAR-NK Cells Targeting Mesothelin (MSLN) and MUC1 in Advanced Pancreatic… | Pancreatic Ductal Adenocarcinoma (PDAC) | Recruiting | 2026-06-04 |
| NCT07622940 | Dual-Target CLDN18.2/HER2 CAR-NK Cells for Advanced Esophageal Adenocarcinoma | Recurrent or Metastatic Esophageal Adenocarcinoma | Recruiting | 2026-06-03 |
| NCT07617753 | Dual-Targeting CAR-NK Cells for Recurrent Ovarian Cancer (MSLN, FRα, MUC16) pt2 | Epithelial Ovarian Cancer | Recruiting | 2026-06-01 |
| NCT07617805 | EGFR/HER2 Dual-Target CAR-NK Cells for Recurrent or Metastatic HNSCC | Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma | Recruiting | 2026-06-01 |
| NCT07598955 | Target-Selected CAR-NK Cells (CD30, CD5, or Mesothelin) for Relapsed/Refractory B2… | B2 Thymoma | Recruiting | 2026-05-20 |
| NCT07589517 | Dual-Targeting CAR-NK Cells in Biomarker-Selected Advanced Colorectal Cancer | Colorectal Cancer | Recruiting | 2026-05-15 |
| NCT07589530 | Phase 1/2 Study of EB-NK-301 (Allogeneic TROP2-CAR NK Cells) in Advanced TROP2-Expressing… | Advanced Solid Tumors | Recruiting | 2026-05-15 |
| NCT07589543 | Dual-Target CAR-NK Cells in Recurrent or Refractory Epithelial Ovarian Cancer | Epithelial Ovarian Cancer | Recruiting | 2026-05-15 |
| NCT07551349 | Dual-target CD70/CAIX CAR-NK Cells for Advanced Clear Cell Renal Cell Carcinoma | Advanced or Metastatic Clear Cell Renal Cell Carcinoma | Recruiting | 2026-04-24 |
| NCT07551362 | Dual-target CLDN18.2/HER2 CAR-NK Cells for Advanced Gastric/GEJ Cancer | Advanced Gastric Adenocarcinoma | Recruiting | 2026-04-24 |
| NCT07523529 | Biomarker-Guided Dual-Target CAR-T Cells for Advanced Solid Tumors | Advanced Unresectable | Recruiting | 2026-04-13 |
| NCT07523542 | SELECT-SLE: Biomarker-Guided CAR-T Target Selection for Refractory Lupus | REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS | Recruiting | 2026-04-13 |
| NCT07523555 | Adaptive Dual-Target CAR-T Cells for Relapsed or Refractory Hematologic Malignancies | Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia | Recruiting | 2026-04-13 |
| NCT07510802 | Dual-Target CAR-NK Cells for Advanced Breast Cancer HER2+ TNBC | Breast Cancer (Advanced/Metastatic) | Recruiting | 2026-04-06 |
| NCT07510815 | Dual-Target MSLN/FAP CAR-NK Cells for Pleural and Peritoneal Mesothelioma | Malignant Pleural Mesotheliomas | Recruiting | 2026-04-06 |
| NCT07510828 | PRISM-NK: Precision-Matched Allogeneic Single- or Dual-Target CAR-NK Cells for Advanced… | Advanced or Metastatic Solid Tumors | Recruiting | 2026-04-06 |
| NCT07500220 | Dual-Target GPC3/B7-H3 CAR-NK Cells for Advanced HCC | Advanced Hepatocellular Carcinoma (HCC) | Recruiting | 2026-03-30 |
| NCT07502287 | Dual-Target GD2/B7-H3 CAR-NK Cells for Pediatric Relapsed or Refractory Neuroblastoma | Relapsed Neuroblastoma | Recruiting | 2026-03-30 |
| NCT07486089 | Dual-Target CAR-NK Cells for Advanced Breast Cancer (HER2+ and TNBC) | Breast Cancer (Locally Advanced or Metastatic) | Recruiting | 2026-03-20 |
| NCT07480213 | Adaptive Phase 1/2 Study of Dual-Target CAR-NK Cells in Relapsed/Refractory Small Cell… | Small Cell Lung Cancer (SCLC) | Recruiting | 2026-03-18 |
| NCT07480928 | Dual-Targeting CAR-NK Cells Targeting Mesothelin (MSLN) and MUC1 in Advanced Pancreatic… | Pancreatic Ductal Adenocarcinoma (PDAC) | Recruiting | 2026-03-18 |
Lung Cancer (4) · HER2-Positive Cancer (3) · Ovarian Cancer (3) · Breast Cancer (2) · Colorectal Cancer (2) · Glioblastoma (2) · Glioma (2) · Non-Small Cell Lung Cancer (NSCLC) (2) · Pancreatic Cancer (2) · Small Cell Lung Cancer (2)